Mon, January 9, 2023
Sun, January 8, 2023
Fri, January 6, 2023
Thu, January 5, 2023
Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022

Edward Tenthoff Maintained (SYRS) at Buy with Decreased Target to $20 on, Jan 5th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-20-on-jan-5th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Edward Tenthoff of Piper Sandler, Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Buy with Decreased Target from $27 to $20 on, Jan 5th, 2023.

Edward has made no other calls on SYRS in the last 4 months.



There are 3 other peers that have a rating on SYRS. Out of the 3 peers that are also analyzing SYRS, 0 agree with Edward's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Edward


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $20 on, Tuesday, November 15th, 2022
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $16 on, Tuesday, November 15th, 2022
  • Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $15 on, Tuesday, November 15th, 2022

Publication Contributing Sources